Asthma, Allergies and ObesityNCT01229787
The Relation Between Obesity, Adipose Tissue Content of Fatty Acids and Systemic and Airway Inflammation
An observational study of Asthma, Allergies and Obesity, run by Cyprus International Institute for Environment and Public Health at 1 site in Cyprus.
Trial summary
Obesity has been recognized as a risk factors for developing asthma. In a cohort of 5384 children aged 15-17, we aim to: 1. To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and BMI at age 11-12 years Part II 2. Read more about this study
- Who is it for?
- Ages 15 to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Asthma, Allergies and Obesity
- How many people
- 5,384 participants
- Where
- 1 siteCyprus
- Study dates
- Jan 2007to Dec 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Part I took place in 2007 and children 15-16 and 16-17 years across Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time. The subjects of the second part of the study were selected from the 5384 subjects that had participated in the first part and had matched data on current and past BMI. We targeted subjects for part two of the study with the following criteria:1. Current Wheezers: All active asthmatics across all BMI subgroups. Definition of Current Wheezer: Positive answer to the question in ISAAC questionnaire: "Have you had wheezing in the past 12 months?" 2. Never Wheezers: 700 controls selected in a random way across all BMI groups. Definition of Never Wheezer: Negative answers to both of the following two questions: "Have you ever had wheezing?" and "Have you ever had asthma?"
Who may be able to join
- not applicable
Who cannot join
- not applicable
Trial locations and contacts
1 site in 1 country.
About this study
Obesity has been recognized as a risk factors for developing asthma. In a cohort of 5384 children aged 15-17, we aim to:
- To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and BMI at age 11-12 years Part II
- To investigate the association of BMI in adolescence and BMI at age 11-12 years with:
- Prevalence of allergic sensitization
- Lung function
- Levels of airway inflammation at age 16-18 years
- Severity of asthma
Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.
Read the detailed description
Cross-sectional studies in Northern America, Northern Europe and Asia indicate an increased prevalence and severity of asthma in the obese whereas longitudinal studies have indicated that increasing BMI is associated with increased risk of incident asthma in women. However, the mechanisms through which where-by obesity increases the risk for asthma remain unclear. There are only few studies from North America and Asia that suggested that obesity is associated with increased skin test reactivity and atopic diseases and many more that suggest obesity has no association with atopy. In adult asthmatics, it has also been shown that both medical and surgical weight loss is consistently associated with dramatic improvements in lung function, asthma symptoms, and medication usage. However, in children no study has elaborated on the potential benefits of reducing weight.
Total fat intake has also been associated with the diagnosis of asthma. N-3 fatty acids have been noted to inversely correlate with body fat, while levels of N-6 fatty acids correlated positively with body fat. Increased dietary intake of N-3 fatty acid (such as eicosapentaenoic acid) (mainly fish oils) has been generally associated with protection from asthma, while intake of N-6 fatty acids (such as linoleic acid) may increase asthma risk, although this remains controversial. Linoleic acid may act as a precursor of arachidonic acid which subsequently serves as a precursor of 4-series leukotrienes that are highly active mediators of inflammation.
There are only two studies that investigated the levels of exhaled nitric oxide (ENO) as indicator of airway inflammation in relation with obesity and asthma. One study showed significant increase of ENO with increasing BMI in healthy adults. However, the levels of ENO and exhaled leukotriene B4 were recently found to be increased in lean and obese asthmatic children but not related to their BMI's.
In Southern European countries, there are no representative epidemiological data on the contribution of obesity to asthma burden. In this area of the world, there are also no studies on the effect of important lifestyle factors including diet and physical activity on the association of adiposity with asthma pathophysiology. In addition, no information exists on levels of airways inflammation both in non-asthmatics and asthmatics subjects in relation to body content in fat and the impact of weight reduction on airway inflammation.
In years 2001-2003, a national health survey was conducted in Cyprus focusing on nutrition and physical fitness of all children aged 11-12 years (attending the 6th form of all primary schools). With this project we proposed to approach this group of children in years 2007-2009 to investigate the following hypotheses:
AIMS:
The aims of the study are as follows:
Part I To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and independently with BMI at age 11-12 years Part II
To investigate the association of BMI at age 16-18 and independently of BMI at age 11-12 years with:
- Prevalence of allergic sensitization
- Lung function
- Levels of airway inflammation at age 16-18 years
- Severity of asthma
Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.
PART I METHODOLOGY:
Study population Part I took place during the months of January 2007 to June 2007 and children attending the 1st (15-16 years) and 2nd (16-17 years) classes in all public and private Lyceia schools across the Republic of Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had amongst other assessments anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time.
For the assessment of children's asthma status we used the Greek version of the ISAAC (International Study of Asthma and Allergies in Childhood) core questionnaire supplemented with questions relating to potential person-based risk factors such as the place of birth of the child, ethnic origin of the parents, birth order, parental education level, parental smoking, history of atopy in the immediate family (siblings and parents with a history of asthma, eczema and or hay fever), personal uptake of smoking, pet ownership and place of residence.
All participating students had also their weight, percentage body fat and Body Mass Index (BMI) measured. The subjects' BMI had been classified as normal weight, overweight or obese according to sex and age specific cut-offs (six months intervals), suggested by the International Obesity Task Force (IOTF).
Compilation of Dataset
An effort to match subjects on the 2007 cross-sectional database with subjects on the 2001-2002 old cross-sectional database was carried out using various matching parameters. A dataset of 5384 subjects was constructed with matched BMI values in 2007 (aged 15-17 years) and in 2001-2003 (aged 11-12 years).
Statistical Analysis
Using answers to the basic questions for asthma and respiratory morbidity of the ISAAC questionnaire the case definition was further refined to:
- Active asthma: positive answers to questions on ever having asthma and current wheeze and or night time cough unrelated to colds in the past 12 months
- Inactive asthma: positive answer to question on ever having asthma and negative answers to questions for current wheeze and night time cough unrelated to colds in the past 12 months
- Respiratory symptoms without asthma: negative answer to question on ever having asthma and positive answer(s) to questions on current wheeze and or night time cough unrelated to colds in the past 12 months.
The associations between disease outcomes and obesity predictors (BMI z-score and body fat %), were analyzed through univariate analysis and the odds ratio (OR) were calculated with 95% confidence intervals (CI). In addition to the univariate analysis, multiple logistic regression was also performed to further investigate the associations of obesity predictors and disease outcomes adjusting for confounders and stratifying by significant effect modifiers. Statistical significance was set at P < 0.05.
- Conditions
- Asthma, Allergies and Obesity
- Keywords
- asthma, allergies, obesity
- Medical subject headings
- Asthma, Hypersensitivity, Obesity
What is being measured
The primary outcome is the main question the study is designed to answer.
The association between asthma prevalence in adolescence and obsity in adolescence and in childhood
To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and at age 11-12 years
Secondary outcomes (1)
Association of BMI in adolescence and in childhood with allergic sensitization and lung function
To investigate the association of BMI in adolescence and BMI at age 11-12 years with:
- Prevalence of allergic sensitization
- Lung function
- Levels of airway inflammation at age 16-18 years
- Severity of asthma
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2010 (estimated)
- Study startJan 2007
- Study completionDec 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Asthma, Allergies and ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Cross-sectional
- Enrolment
- 5,384 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cyprus International Institute for Environment and Public Health
- Sponsor type
- University, hospital or other
- Collaborators
- Merck Sharp & Dohme LLC
- Investigators
- Panayiotis Yiallouros, MD, PhD, Principal investigator, Cyprus International Insitute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01229787
- Sponsor's protocol ID
- CIIRespiratory1
- Status last verified
- Jul 2009
- First submitted
- 27 Oct 2010
- Last updated
- 28 Oct 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relation Between Obesity, Adipose Tissue Content of Fatty Acids and Systemic and Airway Inflammation
- ClinicalTrials.gov ID
- NCT01229787
- Acronym / sponsor ID
- CIIRespiratory1
- Conditions
- Asthma, Allergies and Obesity
- Keywords
- asthma, allergies, obesity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 5,384 participants (actual)
- Lead sponsor
- Cyprus International Institute for Environment and Public HealthUniversity, hospital or other
- Collaborators
- Merck Sharp & Dohme LLC
- Study start
- Jan 2007
- Study completion
- Dec 2009 (actual)
- First posted
- 28 Oct 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Obesity has been recognized as a risk factors for developing asthma. In a cohort of 5384 children aged 15-17, we aim to:
- To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and BMI at age 11-12 years Part II
- To investigate the association of BMI in adolescence and BMI at age 11-12 years with:
- Prevalence of allergic sensitization
- Lung function
- Levels of airway inflammation at age 16-18 years
- Severity of asthma
Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.
Detailed description
Cross-sectional studies in Northern America, Northern Europe and Asia indicate an increased prevalence and severity of asthma in the obese whereas longitudinal studies have indicated that increasing BMI is associated with increased risk of incident asthma in women. However, the mechanisms through which where-by obesity increases the risk for asthma remain unclear. There are only few studies from North America and Asia that suggested that obesity is associated with increased skin test reactivity and atopic diseases and many more that suggest obesity has no association with atopy. In adult asthmatics, it has also been shown that both medical and surgical weight loss is consistently associated with dramatic improvements in lung function, asthma symptoms, and medication usage. However, in children no study has elaborated on the potential benefits of reducing weight.
Total fat intake has also been associated with the diagnosis of asthma. N-3 fatty acids have been noted to inversely correlate with body fat, while levels of N-6 fatty acids correlated positively with body fat. Increased dietary intake of N-3 fatty acid (such as eicosapentaenoic acid) (mainly fish oils) has been generally associated with protection from asthma, while intake of N-6 fatty acids (such as linoleic acid) may increase asthma risk, although this remains controversial. Linoleic acid may act as a precursor of arachidonic acid which subsequently serves as a precursor of 4-series leukotrienes that are highly active mediators of inflammation.
There are only two studies that investigated the levels of exhaled nitric oxide (ENO) as indicator of airway inflammation in relation with obesity and asthma. One study showed significant increase of ENO with increasing BMI in healthy adults. However, the levels of ENO and exhaled leukotriene B4 were recently found to be increased in lean and obese asthmatic children but not related to their BMI's.
In Southern European countries, there are no representative epidemiological data on the contribution of obesity to asthma burden. In this area of the world, there are also no studies on the effect of important lifestyle factors including diet and physical activity on the association of adiposity with asthma pathophysiology. In addition, no information exists on levels of airways inflammation both in non-asthmatics and asthmatics subjects in relation to body content in fat and the impact of weight reduction on airway inflammation.
In years 2001-2003, a national health survey was conducted in Cyprus focusing on nutrition and physical fitness of all children aged 11-12 years (attending the 6th form of all primary schools). With this project we proposed to approach this group of children in years 2007-2009 to investigate the following hypotheses:
AIMS:
The aims of the study are as follows:
Part I To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and independently with BMI at age 11-12 years Part II
To investigate the association of BMI at age 16-18 and independently of BMI at age 11-12 years with:
- Prevalence of allergic sensitization
- Lung function
- Levels of airway inflammation at age 16-18 years
- Severity of asthma
Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.
PART I METHODOLOGY:
Study population Part I took place during the months of January 2007 to June 2007 and children attending the 1st (15-16 years) and 2nd (16-17 years) classes in all public and private Lyceia schools across the Republic of Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had amongst other assessments anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time.
For the assessment of children's asthma status we used the Greek version of the ISAAC (International Study of Asthma and Allergies in Childhood) core questionnaire supplemented with questions relating to potential person-based risk factors such as the place of birth of the child, ethnic origin of the parents, birth order, parental education level, parental smoking, history of atopy in the immediate family (siblings and parents with a history of asthma, eczema and or hay fever), personal uptake of smoking, pet ownership and place of residence.
All participating students had also their weight, percentage body fat and Body Mass Index (BMI) measured. The subjects' BMI had been classified as normal weight, overweight or obese according to sex and age specific cut-offs (six months intervals), suggested by the International Obesity Task Force (IOTF).
Compilation of Dataset
An effort to match subjects on the 2007 cross-sectional database with subjects on the 2001-2002 old cross-sectional database was carried out using various matching parameters. A dataset of 5384 subjects was constructed with matched BMI values in 2007 (aged 15-17 years) and in 2001-2003 (aged 11-12 years).
Statistical Analysis
Using answers to the basic questions for asthma and respiratory morbidity of the ISAAC questionnaire the case definition was further refined to:
- Active asthma: positive answers to questions on ever having asthma and current wheeze and or night time cough unrelated to colds in the past 12 months
- Inactive asthma: positive answer to question on ever having asthma and negative answers to questions for current wheeze and night time cough unrelated to colds in the past 12 months
- Respiratory symptoms without asthma: negative answer to question on ever having asthma and positive answer(s) to questions on current wheeze and or night time cough unrelated to colds in the past 12 months.
The associations between disease outcomes and obesity predictors (BMI z-score and body fat %), were analyzed through univariate analysis and the odds ratio (OR) were calculated with 95% confidence intervals (CI). In addition to the univariate analysis, multiple logistic regression was also performed to further investigate the associations of obesity predictors and disease outcomes adjusting for confounders and stratifying by significant effect modifiers. Statistical significance was set at P < 0.05.
Study design
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 15 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Part I took place in 2007 and children 15-16 and 16-17 years across Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time. The subjects of the second part of the study were selected from the 5384 subjects that had participated in the first part and had matched data on current and past BMI. We targeted subjects for part two of the study with the following criteria:1. Current Wheezers: All active asthmatics across all BMI subgroups. Definition of Current Wheezer: Positive answer to the question in ISAAC questionnaire: "Have you had wheezing in the past 12 months?" 2. Never Wheezers: 700 controls selected in a random way across all BMI groups. Definition of Never Wheezer: Negative answers to both of the following two questions: "Have you ever had wheezing?" and "Have you ever had asthma?"
Key inclusion criteria (1 listed)
- not applicable
Key exclusion criteria (1 listed)
- not applicable
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The association between asthma prevalence in adolescence and obsity in adolescence and in childhood
To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and at age 11-12 years
1 secondary outcome
Association of BMI in adolescence and in childhood with allergic sensitization and lung function
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2010.
Related trials for Asthma, Allergies and Obesity
RecruitingPhase 2
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Asthma, Asthma Chronic
Active, not recruiting
The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions
Type 1 Diabetes Mellitus, Obesity
Active, not recruitingPhase 2
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Asthma
Active, not recruitingObservational study
Project Viva: a Longitudinal Study of Health for the Next Generation
Pediatric Obesity
Active, not recruitingObservational study
First-Line Diagnostic Investigations for Suspected Adult Asthma
Asthma (Diagnosis)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Panayiotis Yiallouros, MD, PhD principal investigator
Cyprus International Insitute
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Asthma, Allergies and Obesity, run by Cyprus International Institute for Environment and Public Health at 1 site in Cyprus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Oct 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The association between asthma prevalence in adolescence and obsity in adolescence and in childhood. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2010.